Translate
Nuvation Bio Inc
About
Nuvation Bio Inc (NYSE:NUVB) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Nuvation Bio Announces IBTROZI® (Taletrectinib) Showed Highly Durable Responses in Longer-Term Follow-up Data from Pivotal Studies Presented at AACR 2026
Yesterday
Nuvation Bio to Report First Quarter 2026 Financial Results and Provide Business Update on May 4, 2026
Mar 2 2026
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Feb 17 2026
Nuvation Bio to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 2, 2026
Feb 9 2026
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
Financials
Revenue
$62.9 M
Market Cap
$1.61 B
EPS
-0.60